NVRO (Nevro Corporation) Prakiraan pendapatan perusahaan
Nevro Corp. is integrating AI into implants to combat chronic pain, leveraging the engineering potential of HFX. The company is pursuing profitability through expansion into the diabetic neuropathy segment and the release of new devices. Current focus has shifted toward pipeline stabilization and the personalization of therapy. The company's future sales trajectory on GURU.Markets reflects expectation dynamics, where the value 0.41 represents the current metric.
Rincian analitis lan laporan data perusahaan Nevro Corp (NVRO)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Nevro Corp.|NVRO - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal Nevro Corporation|NVRO - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Nevro Corp|NVRO - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Nevro|Indikator likuiditas cepet nevro.com
- statistik bathi lan rasio pasar:
NVRO - Bathi pungkasan|Proyeksi bathi mangsa ngarep Nevro Corp.|NVRO - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Nevro|NVRO - Rasio rega marang wutah bathi resik|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Nevro Corp|NVRO - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Nevro|NVRO - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan nevro.com|NVRO - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Nevro Corp.
- data dodolan lan asil:
Analisis fundamental perusahaan:Nevro Corp.
The scale of Nevro Corp. (NVRO) operations depends directly on the demand dynamics for spinal cord stimulation systems. This indicator captures the real pace of business expansion, revealing the gap between inertial growth and the actual decline in market share. Investors distinguish model resilience from market noise by analyzing the acceleration or deceleration of expansion. The projected sales volume signals the risk of overpaying for the asset amid pressure from medtech behemoths.
Analisis perusahaan pesaing
Volume dodolan mangsa ngarep perusahaan DXCM (DexCom, Inc.)|PEN (penumbrainc.com) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Novanta NOVT|HAE - Volume dodolan mangsa ngarep perusahaan|Inspire Sleep - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Procept|CNMD: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan PLSE|INMD (InMode) - Prakiraan volume dodolan|Picard Medical Corp (PMI) - Dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan SRDX|Volume dodolan mangsa ngarep perusahaan Eversense SENS|Prakiraan volume dodolan NPCE (NeuroPace, Inc.)|Prakiraan volume dodolan Tactile Systems Technology, Inc. TCMD|SNWV - Prakiraan pendapatan perusahaan|OM: Prakiraan pendapatan perusahaan|ELMD (smartvest.com) - Volume dodolan mangsa ngarep perusahaan|LENSAR Inc - Pendapatan mangsa ngarep perusahaan|RCEL (AVITA Medical, Inc.) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Profound Medical Corporation PROF|Prakiraan pendapatan perusahaan Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Prakiraan dodolan perusahaan|Apyx Medical Corporation - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan IceCure Medical Ltd. ICCM|Pulmonx Corp. - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan SRTS (Sensus Healthcare Inc)|Prakiraan pendapatan perusahaan Zynex Inc|Volume dodolan mangsa ngarep perusahaan electroCore Medical (ECOR)|Prakiraan volume dodolan RBOT|IINN - Volume dodolan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan SeaStar Medical ICU|IRIX: Prakiraan pendapatan perusahaan|INBS: Volume dodolan mangsa ngarep perusahaan|Beyond Air, Inc. - Prakiraan volume pendapatan perusahaan|Profusa Inc (PFSA) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan SSKN|GCTK (GlucoTrack, Inc.) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan nanovibronix.com NAOV|Volume dodolan mangsa ngarep perusahaan VERO (Venus Concept Corp)|Prakiraan pendapatan perusahaan NUWE (Nuwellis Corp)|Prakiraan pendapatan perusahaan Aethlon Medical AEMD|Pendapatan mangsa ngarep perusahaan ASXC|AVGR - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan BioSig|CUTR (Cutera, Inc) - Volume dodolan mangsa ngarep perusahaan|Know Labs Corporation - Pendapatan mangsa ngarep perusahaan|NARI (Inari Medical, Inc.) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan ReShape Lifesciences Inc (RSLS)|Prakiraan pendapatan perusahaan Silk Road Medical (SILK)
